Showing results (251-260 of 476) with videos related to
Sort By:
Pageof 48
The Journal of Biological Chemistry|December 15, 1985
Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cellsF Beguinot, C R Kahn, A C Moses, et al.The British Journal of Cancer. Supplement|March 1, 1975
Results of combination chemotherapy of non-Hodgkin's lymphomaP S Schein, B A Chabner, G P Canellos, et al.Molecular Pharmacology|September 1, 1983
Cytotoxicity of estramustine, a steroid-nitrogen mustard derivative, through non-DNA targetsK D Tew, L C Erickson, G White, et al.Cancer Research|October 1, 1981
Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosoureaP V Woolley, P V Luc, A Rahman, et al.Cancer Treatment Reports|October 1, 1980
Phase I clinical trial of spirogermaniumP S Schein, M Slavik, T Smythe, et al.National Cancer Institute Monograph|October 1, 1975
Use of peritoneoscopy for initial staging and posttherapy evaluation of patients with ovarian carcinomaS H Rosenoff, R C Young, B Chabner, et al.Journal of Cellular Physiology|September 1, 1986
Persistent infection with a nontransforming RNA virus leads to impaired growth factor receptors and responseE M Verdin, E Maratos-Flier, J L Carpentier, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993
Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1B Cheatham, S E Shoelson, K Yamada, et al.The New England Journal of Medicine|July 19, 1984
Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathersJ H Warram, A S Krolewski, M S Gottlieb, et al.The Journal of Biological Chemistry|April 1, 2000
Gab-1-mediated IGF-1 signaling in IRS-1-deficient 3T3 fibroblastsJ N Winnay, J C Brüning, D J Burks, et al.Pageof 48